Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1097-110.

An overview of current pharmacotherapy in perennial rhinitis.

Author information

  • 1Allergy and Asthma Medical Group and Research Center, San Diego, CA 92123, USA.

Abstract

BACKGROUND:

Individuals with rhinitis experience significant morbidity due to their disease. Research and clinical care to reduce this suffering are important.

OBJECTIVE:

To review the pharmacological agents that have been developed for the treatment of perennial rhinitis.

METHOD:

Literature review of human studies.

RESULTS:

Medication classes include antihistamines, decongestants, anticholinergics, cromolyn sodium, and corticosteroids. These vary in regard to their pharmacology, efficacy, and adverse effects. Compliance and cost issues are also critical components of the therapeutic regimen.

CONCLUSION:

Carefully chosen pharmacotherapy based on an understanding of the pathophysiology of the disease, knowledge of the potential of medications, and commitment to an ongoing patient/physician education and monitoring program can lead to improved well-being for individuals with perennial rhinitis.

PMID:
7538519
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk